These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 11992286)

  • 1. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
    Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
    J Infect Dis; 1999 Apr; 179(4):1038-41. PubMed ID: 10068606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases.
    Liles WC
    Semin Respir Infect; 2001 Mar; 16(1):11-7. PubMed ID: 11309708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocyte-macrophage colony-stimulating factor.
    Mochida-Nishimura K; Akagawa KS; Rich EA
    Cell Immunol; 2001 Nov; 214(1):81-8. PubMed ID: 11902832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factors in the prevention and management of infectious diseases.
    Page AV; Liles WC
    Infect Dis Clin North Am; 2011 Dec; 25(4):803-17. PubMed ID: 22054757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytokines in the treatment of blood diseases].
    Robak T
    Acta Haematol Pol; 1995; 26(2 Suppl 1):72-8. PubMed ID: 7544526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia.
    Dignani MC; Rex JH; Chan KW; Dow G; deMagalhaes-Silverman M; Maddox A; Walsh T; Anaissie E
    Cancer; 2005 Jul; 104(1):199-204. PubMed ID: 15929126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY; Xu B; Sun J; Yang Y; Niu JN
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of myeloid development and function by colony stimulating factors.
    Barreda DR; Hanington PC; Belosevic M
    Dev Comp Immunol; 2004 May; 28(5):509-54. PubMed ID: 15062647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma macrophage colony-stimulating factor, granulocyte macrophage colony-stimulating factor and granulocyte colony-stimulating factor levels in continuous ambulatory peritoneal dialysis patients].
    Saionji K; Hamada T; Higurashi H; Shimizu T; Hukuromoto T; Takeshima S; Kurotani W
    Rinsho Byori; 1997 May; 45(5):493-7. PubMed ID: 9170979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologicals and hematopoietic cytokines in prevention or treatment of infections in immunocompromised hosts.
    Roilides E; Pizzo PA
    Hematol Oncol Clin North Am; 1993 Aug; 7(4):841-64. PubMed ID: 7689074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology of granulocyte and macrophage colony-stimulating factors in host defense.
    Weisbart RH; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):401-9. PubMed ID: 2483721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.